Publication Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT). Rengasamy M, Shenoy M, Dogra S, et al. Indian dermatology online journal. 2020; 11 (4) : 502-519. Download PDF
Publication Pharmacologic management of infection. Van Der Werf T, Barogui Y, Converse P, et al. Expert review of clinical pharmacology. 2020; Download PDF
Publication Prevention of transmission of leprosy: The current scenario. Palit A, Kar H. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123. Download PDF
Publication Unanswered questions on the safety of MDT-U - Reply. Penna GO, Gonçalves HSá, Pontes MAA. Anais brasileiros de dermatologia. 2019; 94 (4) : 500. Download PDF
Publication 1350. Clofazimine as an oral companion drug for treatment of Mycobacterium abscessus complex infections Yong J, Lip Chew K, Tambyah P. Open Forum Infectious Diseases. 2019; Download PDF
Publication Unanswered questions on the safety of MDT-U. Barve A. Anais brasileiros de dermatologia. 2019; 94 (4) : 499. Download PDF
Publication Diet and nutrition: An important risk factor in leprosy. Dwivedi VP, Banerjee A, Das I, et al. Microbial pathogenesis. 2019;
Publication Emergence and transmission of drug/multidrug-resistant Mycobacterium leprae in a former leprosy colony in the Brazilian Amazon. Rosa PS, D'Espindula HR S, Melo AC L, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019; Download PDF
Publication Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Molinelli E, Paolinelli M, Campanati A, et al. Expert opinion on drug metabolism & toxicology. 2019;
Publication Insights of synthetic analogues of anti-leprosy agents. Bera S, Mondal D. Bioorganic & medicinal chemistry. 2019;
Publication Typology and pathogenesis of neuropathic pain with leprosy Belopasov V V. Russian Medical Review. 2018; Download PDF
Publication An overview of the treatment of Mycobacterium ulcerans infection (Buruli ulcer). Meher-Homji Z, Johnson PD R. Current treatment options in infectious diseases. 2018;
Publication Nanosystems as modulators of intestinal dapsone and clofazimine delivery. Chaves LL, Costa Lima SA, Vieira AC C, et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;
Publication Hemolytic anemia incident in leprosy patients receiving multi-drug therapy at Haji Adam Malik Central Hospital, Medan-Indonesia. Muhaira WT, Darmi M, Lubis RD. Bali medical journal. 2018; 7 (2) : 442-446. Download PDF
Publication Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature. Budge PJ, Herbert C, Andersen B, et al. PLoS neglected tropical diseases. 2018; 12 (5) : e0006454. Download PDF
Publication Poor treatment compliance leads to a higher mutation for rifampicin resistance in multibacillary leprosy patients Siskawati Y, Effendi EH, Legiawati L, et al. Medical journal of Indonesia. 2018; 27 (4) : 237-243. Download PDF
Publication Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. Cruz RCS, Bührer-Sékula S, Penna MLF, et al. Anais brasileiros de dermatologia. 2017; 92 (6) : 761-773. Download PDF
Publication Feline leprosy due to Candidatus 'Mycobacterium tarwinense'. O'Brien CR, Malik R, Globan M, et al. Journal of feline medicine and surgery. 2017; 19 (5) : 498-512.
Publication [The nurse's view on leprosy treatment in primary health care] Dayanne Alves Ribeiro M, Silva Castillo I, Carlos Araujo Silva J, et al. Revista brasileira em promoção da saúde . 2017; 30 (2) : 221-228. Download PDF
Publication Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy. Joseph P, Ponnaiya J, Das M, et al. Indian journal of leprosy. 2016; 88 (3) : 147-58. Download PDF
